Active components of Dengzhan Shengmai ameliorate cognitive impairment by facilitating hippocampal long-term potentiation via the NMDA receptor-mediated Ca2+/CaMKII pathwayCongyu Ma, Jinlan Zhang, Jian‐Dong Jiang et al.|Journal of Pharmaceutical Analysis|2023Cited by 3
Corrigendum to “Active components of Dengzhan Shengmai ameliorate cognitive impairment by facilitating hippocampal long-term potentiation via the NMDA receptor-mediated Ca2+/CaMKII pathway” [J. Pharm. Anal. 14 (2024) 435–438]Congyu Ma, Jinlan Zhang, Ning Sheng et al.|Journal of Pharmaceutical Analysis|2024Cited by 0